Bosnic-Anticevic, S.
5 November, 2015
The role of medications in the management of asthma is central to good asthma control, and this is reflected in asthma management guidelines globally. However, when it comes to the management of asthma medicine use in practice, there are significant issues associated with the inappropriate use of inhaled medications.
Beasley, R.
5 November, 2015
Presentation to Respiratory Conference New Zealand November 2015
Telfar Barnard, L., Baker, M., Pierse, N., & Zhang, J.
4 April, 2015
This report covers six respiratory disease indicators: asthma, bronchiectasis, childhood bronchiolitis and pneumonia, chronic obstructive pulmonary disease (COPD), and total respiratory disease.
Chan, A., Stewart, A., Harrison, J., Camargo, C., Black, P., Mitchell, E.
12 March, 2015
We did a randomised controlled trial in patients aged 6–15 years who attended the regional emergency department in Auckland, New Zealand with an asthma exacerbation and were on regular inhaled corticosteroids.
Global Asthma Network
30 October, 2014
The Global Asthma Report 2014 includes strategic and practical recommendations and valuable information for governments, health organisations, health professionals, and people with asthma.
Pene, G.
26 August, 2013
We spend more than 75% of our time indoors, so keeping the houses of people with asthma and COPD warm and dry is crucial for maintaining their health.
Keall, M.
1 November, 2012
Damp and mould in homes have been established as risk factors for respiratory health. There is a need for a relatively straightforward assessment of the home that quantifies this risk.
Perrin, K. et al
19 May, 2011
Conclusion: High concentration oxygen therapy causes a clinically significant increase in PtCO2 in patients presenting with severe exacerbations of asthma. A titrated oxygen regime is recommended in the treatment of severe asthma, in which oxygen is administered only to patients with hypoxaemia, in a dose that relieves hypoxaemia without causing hyperoxaemia
Taylor, R.
12 December, 2010
In a randomized cross-over trial, cromoglycate, formoterol and montelukast were equally effective in low FENO patients.
Professor Lutz Beckert
1 March, 2018
Research review with a focus on Asthma